Anticancer activity of plasma activated medium and its underlying mechanisms: Combined experimental and computational study (Anticancer-PAM).
The impact of autophagy-driven intercellular communication in melanoma vasculature to restrain T cell-mediated anticancer immunity
Adherence to oral anticancer drugs: influencing factors and underlying processes, usual care and healthcare professionals' perceptions of adherence to oral anticancer drugs
Predicted concentrations of anticancer drugs in the aquatic environment: What should we monitor and where should we treat?
Royleanone diterpenoid exhibits potent anticancer effects in LNCaP human prostate carcinoma cells by inducing mitochondrial mediated apoptosis, cell cycle arrest, suppression of cell migration and downregulation of mTOR/PI3K/AKT signalling pathway.
Adherence to oral anticancer drugs (OAD) in patients (pts) with metastatic renal cancer (mRCC): First results of the prospective observational multicenter IPSOC study (Investigating Patient Satisfaction with Oral Anti-cancer Treatment)
